| 股票 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 福瑞医科 300049 | 医疗器械 | 67.2 | 45.5 | 1.34 | 5.68 | 0.4% | 26% | 74% | 14% | 0.5 | 2.0% | +16% | +124% | -40% | -33% | -58% | 60% | 112 |
| 圣湘生物 688289 | 医疗器械 | 68.4 | 35.8 | 1.70 | 1.31 | 3.3% | 112% | 72% | 13% | 5.5 | -0.6% | -37% | -15% | -14% | -27% | -36% | 35% | 92 |
| 中源协和 600645 | 医疗器械 | 74.4 | — | — | 2.33 | — | — | 69% | 10% | 0.2 | 3.2% | -2% | +31% | -26% | -34% | -49% | 44% | 87 |
| 微电生理 688351 | 医疗器械 | 148.2 | 131.6 | 3.21 | 4.78 | 0.1% | 19% | 64% | 9% | 0.1 | -0.3% | +21% | +22% | -20% | -29% | -36% | 43% | 87 |
| 英诺特 688253 | 医疗器械 | 154.8 | — | — | 3.85 | 0.8% | 31% | 77% | 5% | 0.1 | 0.3% | -2% | -16% | +92% | +75% | -24% | 54% | 78 |
| 健信超导 688805 | 医疗器械 | 75.1 | 88.1 | 3.83 | 5.68 | 0.7% | 50% | 26% | 10% | 0.0 | -0.6% | +17% | — | -1% | — | -40% | 63% | 69 |
| 超研股份 301602 | 医疗器械 | 63.7 | — | — | 5.18 | 0.9% | 34% | 69% | 8% | — | 1.4% | +6% | — | -25% | -43% | -50% | 38% | 69 |
| 华强科技 688151 | 医疗器械 | 119.0 | — | — | 1.36 | 0.3% | 47% | 23% | 13% | — | 0.5% | +2% | +33% | -19% | -34% | -44% | 38% | 57 |
| 三友医疗 688085 | 医疗器械 | 92.6 | 47.9 | 0.96 | 2.35 | 0.1% | 10% | 80% | 13% | 0.3 | 1.0% | -6% | +2% | -16% | -33% | -51% | 46% | 50 |
| 国科恒泰 301370 | 医疗器械 | 152.8 | — | — | 1.66 | 1.4% | 33% | 12% | 9% | 7.8 | 10.7% | +3% | +9% | -25% | -23% | -35% | 28% | 41 |
| 安旭生物 688075 | 医疗器械 | — | — | — | 0.74 | 2.7% | 80% | 42% | 14% | 2.9 | -3.4% | -58% | +7% | -23% | -30% | -38% | 26% | 37 |
| 透景生命 300642 | 医疗器械 | 228.4 | 216.5 | 1.34 | 1.96 | 0.9% | 70% | 66% | 19% | 4.7 | 4.8% | -20% | +32% | -5% | -39% | -64% | 59% | 28 |
| 奥精医疗 688613 | 医疗器械 | 251.0 | — | — | 1.51 | 0.2% | 30% | 83% | 11% | 1.0 | -1.5% | -3% | +13% | -22% | -24% | -54% | 51% | 22 |
| 仁度生物 688193 | 医疗器械 | 108.8 | — | — | 2.17 | 2.3% | 269% | 78% | 7% | 0.1 | 0.7% | -19% | +37% | +1% | -12% | -33% | 41% | 19 |
| 中科美菱 920992 | 医疗器械 | 64.6 | 52.0 | 4.00 | 1.84 | 0.8% | 46% | 36% | 12% | 0.2 | 2.4% | -9% | +28% | -31% | — | — | — | 12 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。